The carbapenemase menace: Do dual mechanisms code for more resistance?

Infection Control and Hospital Epidemiology

Volumn 36, Issue 1, 2015, Pages 116-117

  Kazi, Mubin ^a   Shetty, Anjali ^a   Rodrigues, Camilla ^a  

^a P D HINDUJA NATIONAL HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE; CARBAPENEM DERIVATIVE; CARBAPENEMASE; COLISTIN; DORIPENEM; IMIPENEM; MEROPENEM; METALLO BETA LACTAMASE; METALLO BETA LACTAMASE 1; OXACILLINASE; UNCLASSIFIED DRUG; BACTERIAL PROTEIN;

ANTIBIOTIC SENSITIVITY; BACTERIAL INFECTION; BACTERIUM ISOLATE; CARBAPENEM RESISTANT ENTEROBACTERIACEAE; ENTEROBACTER; ENTEROBACTERIACEAE; HUMAN; INTEGRON; KLEBSIELLA; LETTER; MINIMUM INHIBITORY CONCENTRATION; MULTIPLEX POLYMERASE CHAIN REACTION; VERONA INTEGRON; ANTIBIOTIC RESISTANCE; DRUG EFFECTS; ENZYMOLOGY; ESCHERICHIA COLI; GENETICS; METABOLISM; MICROBIAL SENSITIVITY TEST;

BACTERIAL PROTEINS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CARBAPENEMS; ENTEROBACTER; ENTEROBACTERIACEAE; ESCHERICHIA COLI; HUMANS; KLEBSIELLA; MICROBIAL SENSITIVITY TESTS;

EID: 84922775744     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1017/ice.2014.33     Document Type: Letter

References (3)

1. Gupta N, Limbago BM, Patel JB, Kallen AJ. Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention. Clin Infect Dis 2011;53:60-67.
2. Clinical and Laboratory Standards Institute. M100-S23-Performance standards for antimicrobial susceptibility testing: twenty-third informational supplement. Wayne, PA: Clinical and Laboratory Standards Institute, 2013.
3. Kazi M, Drego L, Nikam C, et al. Molecular characterization of carbapenem resistant Enterobacteriaceae at a tertiary care laboratory in Mumbai. Eur J Clin Microbiol Infect Dis 2014, Sep 27 [Epub ahead of print].